AstraZeneca and Oxford University’s COVID-19 vaccine trials will restart

After being suspended on Tuesday due to a recorded side effect in a patient in the UK, AstraZeneca and Oxford University’s COVID-19 vaccine trials will restart.

The university declared that the UK regulator, the Medicines and Healthcare Products Regulatory Agency outlined that it was safe to continue and that it was predictable that some participants will fall ill in large trials.